elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastiske midler - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
oncaspar
les laboratoires servier - pegaspargase - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - oncaspar er indikert som en komponent i antineoplastisk kombinasjonsterapi ved akutt lymfoblastisk leukemi (all) hos pediatriske pasienter fra fødsel til 18 år, og voksne pasienter.
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
orfiril 600 mg
orifarm as - natriumvalproat - enterotablett - 600 mg
valproat life medical 100 mg/ ml
life medical aps (1) - natriumvalproat - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml
erwinase 10000 e
porton biopharma limited - krisantaspase - pulver til injeksjons-/infusjonsvæske, oppløsning - 10000 e